Cargando…

Reactive or transgenic increase in microglial TYROBP reveals a TREM2‐independent TYROBP–APOE link in wild‐type and Alzheimer's‐related mice

INTRODUCTION: Microglial TYROBP (DAP12) is a network hub and driver in sporadic late‐onset Alzheimer's disease (AD). TYROBP is a cytoplasmic adaptor for TREM2 and other receptors, but little is known about its roles and actions in AD. Herein, we demonstrate that endogenous Tyrobp transcription...

Descripción completa

Detalles Bibliográficos
Autores principales:	Audrain, Mickael, Haure‐Mirande, Jean‐Vianney, Mleczko, Justyna, Wang, Minghui, Griffin, Jennifer K., St George‐Hyslop, Peter H., Fraser, Paul, Zhang, Bin, Gandy, Sam, Ehrlich, Michelle E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938663/ https://www.ncbi.nlm.nih.gov/pubmed/33314529 http://dx.doi.org/10.1002/alz.12256

Ejemplares similares

Microglial TYROBP/DAP12 in Alzheimer’s disease: Transduction of physiological and pathological signals across TREM2
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2022)

Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2017)

Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau
por: Audrain, Mickael, et al.
Publicado: (2018)

Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2018)

Correction: Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2018)

Integrated biology approach reveals molecular and pathological interactions among Alzheimer’s Aβ42, Tau, TREM2, and TYROBP in Drosophila models
por: Sekiya, Michiko, et al.
Publicado: (2018)

CXCR4 and TYROBP mediate the development of atrial fibrillation via inflammation
por: Zhang, Yan‐Fei, et al.
Publicado: (2022)

TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
por: Wu, Ping, et al.
Publicado: (2020)

TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma
por: Liang, Tuo, et al.
Publicado: (2021)

Downregulation of m6A Methyltransferase in the Hippocampus of Tyrobp(–/–) Mice and Implications for Learning and Memory Deficits
por: Lv, Zhanyun, et al.
Publicado: (2022)

The Fgl2 interaction with Tyrobp promotes the proliferation of cutaneous squamous cell carcinoma by regulating ERK-dependent autophagy
por: Zeng, Mei, et al.
Publicado: (2022)

Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma
por: Lu, Jiajie, et al.
Publicado: (2021)

Identification of TYROBP and C1QB as Two Novel Key Genes With Prognostic Value in Gastric Cancer by Network Analysis
por: Jiang, Junjie, et al.
Publicado: (2020)

The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration
por: Li, Jiahua, et al.
Publicado: (2022)

TYROBP-positive endothelial cell-derived TWEAK as a promoter of osteosarcoma progression: insights from single-cell omics
por: Wei, Zhi-qiang, et al.
Publicado: (2023)

Higher TYROBP and lower SOX6 as predictive biomarkers for poor prognosis of clear cell renal cell carcinoma: A pilot study
por: Lv, Xian-Qiang, et al.
Publicado: (2022)

MMP9 and TYROBP affect the survival of circulating tumor cells in clear cell renal cell carcinoma by adapting to tumor immune microenvironment
por: Guo, Lingyu, et al.
Publicado: (2023)

Identifying RBM47, HCK, CD53, TYROBP, and HAVCR2 as Hub Genes in Advanced Atherosclerotic Plaques by Network-Based Analysis and Validation
por: Liu, Chiyu, et al.
Publicado: (2021)

Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer’s disease
por: Castranio, Emilie L., et al.
Publicado: (2023)

Computational Interspecies Translation Between Alzheimer’s Disease Mouse Models and Human Subjects Identifies Innate Immune Complement, TYROBP, and TAM Receptor Agonist Signatures, Distinct From Influences of Aging
por: Lee, Meelim J., et al.
Publicado: (2021)

Transcriptomic Changes Highly Similar to Alzheimer’s Disease Are Observed in a Subpopulation of Individuals During Normal Brain Aging
por: Peng, Shouneng, et al.
Publicado: (2021)

Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology
por: Readhead, B, et al.
Publicado: (2016)

Does Soluble TREM2 Protect Against Alzheimer's Disease?
por: Brown, Guy C., et al.
Publicado: (2022)

TMEM59 interacts with TREM2 and modulates TREM2-dependent microglial activities
por: Liu, Zhaoji, et al.
Publicado: (2020)

VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice
por: El Gaamouch, Farida, et al.
Publicado: (2020)

TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
por: Zheng, Honghua, et al.
Publicado: (2018)

APOE and dementia – resequencing and genotyping in 105,597 individuals
por: Rasmussen, Katrine L., et al.
Publicado: (2020)

miR155, TREM2, INPP5D: Disease stage and cell type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy
por: Gandy, Sam, et al.
Publicado: (2023)

Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy
por: Gandy, Sam, et al.
Publicado: (2023)

Characterization of APOE and TOMM40 allele frequencies in the Japanese population
por: Nishimura, Akira, et al.
Publicado: (2017)

Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
por: Fitz, Nicholas F., et al.
Publicado: (2020)

TREM2 triggers microglial density and age‐related neuronal loss
por: Linnartz‐Gerlach, Bettina, et al.
Publicado: (2018)

Soluble TREM2 induces inflammatory responses and enhances microglial survival
por: Zhong, Li, et al.
Publicado: (2017)

The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives
por: Wolfe, Cody M., et al.
Publicado: (2018)

APOE and TREM2 regulate amyloid responsive microglia in Alzheimer’s disease
por: Nguyen, Aivi T., et al.
Publicado: (2020)

Molecular recognition of the interaction between ApoE and the TREM2 protein
por: Mai, Zhenhua, et al.
Publicado: (2022)

Age stratification corrects bias in estimated hazard of APOE genotype for Alzheimer's disease
por: Liu, Li, et al.
Publicado: (2018)

Intestinal epithelial Notch-1 protects from colorectal mucinous adenocarcinoma
por: Dunkin, David, et al.
Publicado: (2018)

Divergent Neuroinflammatory Regulation of Microglial TREM Expression and Involvement of NF-κB
por: Owens, Rosie, et al.
Publicado: (2017)

Modulation of microglial phenotypes by dexmedetomidine through TREM2 reduces neuroinflammation in heatstroke
por: Li, Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1to2biqfmpv13ff8em3kh6ut0n